Michael Nestor is President & Impax Specialty at Impax Laboratories, LLC (IPXL). They have made 6 open-market trades across 1 company since 2009, most recently 2018-05-04.
CIK 0001196063
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $38K since 2009, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IPXL | 101,396 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2018-02-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IPXL | SELL | 2017-05-31 | 2017-06-01 | $15.00 | $17K | -8.4% | +1.5% | +11.1% |
| IPXL | SELL | 2017-05-17 | 2017-05-17 | $16.48 | $14K | -6.5% | -13.7% | +14.0% |
| IPXL | SELL | 2017-05-12 | 2017-05-15 | $17.11 | $12K | -5.4% | -14.9% | +6.3% |
| IPXL | SELL | 2015-09-10 | 2015-09-14 | $43.56 | $218K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2010-08-13 | 2010-08-17 | $16.06 | $26K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2009-03-13 | 2009-03-17 | $5.59 | $11K | -14.0% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.